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Chemical modification of polymer and blending of suitable additives are the common 
methods used to improve the properties of polyethersulfone (PES) based hemodialysis 
membranes. In this research work, both methods are adopted and novel nanocomposite based 
additives were synthesized and blended with PES alone; and then with chemically modified PES 
(sulfonated PES (S-PES)). The whole research work was divided into three phases. In the first 
phase, the nanocomposites (NCs) were formed by mixing together the acid functionalized 
multiwall carbon nanotubes (f-MWCNT) and two different grades of polyvinylpyrrolidone (PVP-
k90 and PVP-k30) in dimethylformamide and subsequently blended with PES. The f-MWCNT 
contained some hydrophilic functional groups (–COOH, and –OH) and heredity hydrophobic 
carbon part, which made it dual nature. On one side, it carbon part created sites for attachment for 
the hydrophobic polymer (PES) by hydrophobic–hydrophobic interaction and π–π stacking, 
whereas on the other side, its hydrophilic acid and hydroxyl groups attracted the hydrophilic 
sides of PVP by hydrogen bonding, dipole–dipole interaction and dispersion forces. Thus, f-
MWCNT acted as the anchoring material between the PVP and PES in the membrane that also 
greatly reduced the leaching process of the additives and stabilize the membrane composition as 
shown by elution ratio test. The Fourier transform infrared spectroscopy spectra of fabricated 
membranes revealed that both types of NCs were physically bonded with PES by hydrogen 
bonding and the addition of NCs to PES, improved the internal capillary system of membranes as 
confirmed by field emission scanning electron microscope analysis. The results showed that f-
MWCNT/PVP-k90 based membranes exhibited better performance than f-MWCNT/PVP-k30 
based membranes in terms of flux rate, rejection rate and biocompatibility. The results from 
dialysis of uremic solutes unveiled that membrane formed by PVP-k90 based NCs demonstrated 
superior performance with 56.30%, 55.08% and 27.90% clearance ratio of  urea, creatinine and 
lysozyme solutes, respectively. In the second phase, two best performance membranes of f-
MWCNT/PVP-k90 NCs based were selected and then blended with variable ratio of S-PES. The 
outcome indicated that the blending of S-PES polymer, further enhanced the membrane 
biocompatibility and reduced the protein adsorption (bovine serum albumin, 55% and lysozyme, 
65%), hemolysis process (74.80%) and illustrated longer clotting times than pristine and non-
sulfonated membranes. The clearance ratio of uremic solutes was also improved and reached up 
to 57.3%, 57.1% and 32.4% of urea, creatinine and lysozyme, respectively. Thus, the blending of 
S-PES and NCs in the PES membrane greatly improved the biocompatibility and removal ability 
of uremic solutes. In the third and final phase, the hollow fiber (HF) membranes were spun using 
S-PES and PVPk90/f-MWCNT based NCs and the HF membrane characteristics and dialysis 
performances were evaluated. The results showed that HF membrane had a good flux rate 
(29.8l/h.m
2
.bar), low molecular weight cut off (29-34 kDa) than pristine PES membranes. The 
dialysis tests confirmed that the HF membranes illustrated 72.7%, 75.1% and 35.4% clearance 
ratio of urea, creatinine and lysozyme solutes, especially. Thus, the blending of S-PES and NCs 
in the PES membrane highly improved the biocompatibility and removal ability of uremic solutes 
and it can be used in commercial grade dialyzers.  






 Pengubahsuaian kimia untuk polimer serta pengadunan bahan tambah yang 
bersesuaian adalah kaedah biasa yang dilakukan untuk menambahbaik ciri-ciri bagi membran 
hemodialisis yang berasaskan polietersulfon (PES). Dalam kerja penyelidikan ini, kedua-dua 
kaedah digunakan iaitu nano-komposit (NCs) novel berasaskan bahan tambah telah disintesis 
kemudian diadunkan dengan PES sahaja; dan kemudiannya PES diubahsuai secara kimia (PES 
tersulfonat, (S-PES)). Penyelidikan ini telah dibahagikan kepada tiga fasa. Dalam fasa pertama, 
NCs telah dibentuk dengan mencampurkan bersama-sama tiub nano karbon berbilang dinding 
yang difungsikan dengan f-MWCNT dan dua jenis polivinilpirolidon yang berbeza gred (PVP-
k90 dan PVP-k30) dalam dimetilformamid dan seterusnya diadunkan dengan PES. Asid f-
MWCNT mengandungi beberapa kumpulan berfungsi hidrofilik (-COOH dan -OH) dan bahagian 
karbon hidrofobik, yang menjadikan ia mengandungi dua sifat. Pada satu bahagian, karbon 
menyediakan tapak untuk lekatan bagi polimer hidrofobik (PES) dengan interaksi hidrofobik-
hidrofobik dan penyusunan π-π, manakala di sisi lain, asid hidrofilik dan kumpulan hidroksil 
ditarik ke bahagian hidrofilik PVP oleh ikatan hidrogen, interaksi dwikutub-dwikutub dan 
penyebaran daya. Oleh itu, f-MWCNT telah bertindak sebagai bahan teras antara PVP dan PES 
dalam membran yang juga dengan banyaknya mengurangkan proses larut lesap bahan tambah 
dan menstabilkan komposisi membran seperti yang ditunjukkan oleh ujian nisbah elusi. 
Keputusan spektrum spektroskopi inframerah transformasi Fourier untuk membran yang terhasil 
mendedahkan bahawa kedua-dua jenis NCs ini secara fizikal terikat dengan PES oleh ikatan 
hidrogen dan penambahan mereka ke PES telah menambah baik sistem kapilari dalaman 
membran seperti yang disahkan oleh analisis mikroskop elektron pengimbas pancaran medan. 
Hasil kajian menunjukkan bahawa membran berasaskan f-MWCNT/PVP-k90 menunjukkan 
prestasi lebih baik daripada membran berasaskan f-MWCNT/PVP-k30 dari segi kadar fluks, 
kadar penolakan dan keserasian bio. Keputusan dialisis bahan larut uremik menunjukkan bahawa 
membran dibentuk dengan PVP-k90 berasaskan NCs telah menunjukkan prestasi yang lebih baik 
dengan 56.30%, 55.08% dan 27.90% masing-masing bagi nisbah kepelepasan bahan larut urea, 
kreatinin dan lisozim. Dalam fasa kedua, dua membran yang mempunyai prestasi terbaik 
berasaskan f-MWCNT/PVP-k90 NCs dipilih dan kemudian diadunkan dengan S-PES mengikut 
nisbah yang berlainan. Hasilnya menunjukkan bahawa pengadunan S-PES polimer telah 
meningkatkan lagi keserasian bio membran dan telah mengurangkan penjerapan protein (bovin 
serum albumin, 55% dan lisozim, 65%), proses hemolisis (74.80%) dan menunjukkan 
pembekuan lebih panjang berbanding asal dan membran tanpa sulfonat. Nisbah pelepasan bahan 
larut uremik juga bertambah baik dan mencapai sehingga 57.3%, 57.1% dan 32.4% masing-
masing untuk urea, kreatinin dan lisozim masing masing. Oleh itu, pengadunan S-PES dan NCs 
di dalam membran PES telah menambah baik keserasian bio dan keupayaan penyingkiran bahan 
larut uremik. Dalam fasa ketiga iaitu fasa terakhir, gentian berongga (HF) membran telah 
dihasilkan oleh S-PES dan PVPk90/f-MWCNT berasaskan NCs dan ciri-ciri membran HF dan 
prestasi dialisis telah dinilai. Hasil kajian menunjukkan bahawa membran HF mempunyai kadar 
fluks yang baik (29.8 l / h.m
2
.bar), berat molekul dengan had potongan yang rendah (29-34 kDa) 
berbanding dengan membran PES asli. Ujian dialisis mengesahkan bahawa membran HF 
menunjukkan 72.7%, 75.1% dan 35.4% masing-masing bagi nisbah pelepasan urea, kreatinin dan 
lisozim bahan larut. Oleh itu, pengadunan S-PES dan NCs dalam membran PES dapat menambah 
baik keserasian bio dan keupayaan penyingkiran bahan larut uremik dan ia boleh digunakan 
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The developments in science and technology have assisted mankind to live 
longer and consumed a large amount of world‘s resources. However, the need to 
sustain life requires a good health condition with better and advance curing methods 
and therapy. Human life is invaluable and there are various factors that affect the 
survival and quality of life. Amongst them are diseases that damaged the human 
kidneys. Kidney, is a bean shaped organ, made up by functional units, called 
nephrons, which received the blood from the renal arteries and after processing 
forced the waste solutes and fluids to move into the urinary bladder and return the 
purified blood to the body circulation. The two key mechanisms are served by the 
kidney. One is the plasma filtration via UF technique that separate the extracellular 
fluid in the glomeruli and the second is the removal of extra water through active and 
passive tubular transport system that also contain dissolved uremic solutes and 
electrolytes (Findlay et al., 2015).  
The origin of kidney disease may be metabolic, vascular, immunologic, 
degenerative, infectious or genetic. The renal failure might be chronic that last up to 
months or years or acute stay for some days or weeks. Acute failure is generally 
related with tubular necrosis, acute glomerulonephritis, ischemia or poisoning with 
nephrotoxins that involved excessive loads of free hemoglobin, aminoglycosides and 
heavy metals. The chronic renal failure is typically initiated by hypertension, 
vascular disease (e.g. diabetes) or chronic glomerulonephritis. If the proper treatment 
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is not taken for acute renal failure, then it will cause the chronic renal failure. The 
human kidney can continue to work until 90% of its function has been lost and keep 
deteriorating and renal failure exceeds 95%. At this stage, survival becomes 
impossible without the replacement therapy (Findlay et al., 2015). 
Supportive therapy like kidney transplant, peritoneal dialysis or hemodialysis 
(HD) are required to prolong life when the human kidney fails to work either as a 
result of painful injury or any other disease. Globally, the number of ESRD patients 
was estimated to be 3,010,000 with  7% growth rate at the end of 2012. Based on a 
previous report, 89% of dialysis patients opted for HD and only 11% chose 
peritoneal dialysis (National Institute of Diabetes and Digestive and Kidney 
Diseases). 
Hemodialysis (HD) method  is a significant  clinical  therapy  that can  
eliminate  toxic  metabolites  from  the  blood of patients whose kidney fail to 
perform and the patient suffered into end stage renal diseases (ESRD) (Miller et al., 
2010). This method has benefited approximately more than one million people per 
year all over the world and the prevalence rate of ESRD is increasing globally (Saran 
et al., 2015). The annual renal data report of United State has covered 57 countries 
and showed that the ESRD incidence rates varied significantly across the globe. 
United States, Mexico and Taiwan described the maximum occurrence of treated 
ESRD at 363-458 persons per million population (pmp). Indonesia, Thailand, 
Portugal, Republic of Korea, Japan and Singapore demonstrated 208–308 pmp, 
whereas other countries showed less than 96 reported incidence rates of treated 
ESRD patients. The highest growths in the treatment of ESRD were observed in 
Mexico (122%), Malaysia (176%), Philippines (185%), Russia (249%), Bangladesh 
(629%) and Thailand (1210%) in 2012/2013 period (Saran et al., 2015). 
According to the U.S. Renal data system (2014) that the medical expenditure 
of ESRD patients in the USA increased from $30.4 billion to $30.9 billion from 2012 
to 2013 with 1.6% growth rate. Whereas, the total global expenditures for ESRD 
patients reached up to $437 billion. It is also estimated that the growth rate of ESRD 
patients will increase in the future due to different diseases, poor quality lifestyles 
3 
 
and improper medical treatments (Saran et al., 2015). Since the necessity of HD 
dialysis will be increasing in the future, thus the dialysis therapy is considered as a 
multi-million dollar industry (National Institute of Diabetes and Digestive and 
Kidney Diseases). 
In Malaysia in 2014, the total registered patients undergoing dialysis were 
34,767 and 6107 new HD cases were registered during the same year. In the last ten 
years, the rate of dialysis acceptance was doubled and reached 203 pmp. Table 1.1 
represents the short summary of the registered and treatment-type of dialysis patients 
in Malaysia. Moreover, there are 758 dialysis centers in the whole country and 
53.2% were funded by government, 12.9% and 31.2% by charity and self supported, 
respectively (Goh et al., 2016). 
Table 1.1:  The registered dialysis patients and the type of treatment supplied to 
ESRD in Malaysia (Goh et al., 2016).  
Year 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 
New Dialysis 
patients 
3167 3709 4103 4640 4952 5305 6073 6690 6985 7055 
New 
Transplants 
172 151 112 131 141 128 127 107 98 81 
Dialysis deaths 1515 1820 1987 2191 2601 3047 3292 3645 4001 4015 
Transplant 
deaths 
49 58 47 59 49 48 55 64 56 45 
Dialyzing at 31st 
December 




1716 1771 1788 1808 1852 1881 1907 1891 1870 1844 
 
During the last decades, membrane technology plays a central role in the 
purification and separation of the biotechnological products. The use of membrane 
based modules progressively enhances both  industrial processes and academic 
science of engineering (van Reis et al., 2007). The membrane filtration system offers 
robust performance, easy availability, less processing time and low cost compared to 
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the other available techniques. These benefits extend the microfiltration (MF) and 
ultrafiltration (UF) membrane systems into various biomedical applications like 
hemofiltration, hemodiafiltration, hemodialysis, plasma collection and 
plasmapheresis (Samtleben et al., 2003; Tullis et al., 2002; Werner et al., 1996; Zhao 
et al., 2013). 
The innovation of asymmetry membrane structures introduced the new era. 
Nowadays, a number of new polymeric materials are available whose properties can 
be upgraded by the use of proper additives and new formulation. In 2004, Membrana 
GmbH launched a performance enhancement technology, in which they used spacer 
yarns woven pattern in HF bundles and optimized the dialysate flow (Membrana, 
2004). Asahi Kasei Medicals Co. Ltd. had launched  a PSf dialyzer modified by 
vitamin-E to reduce the oxidative stress, which reduced the tissue damaging and also 
shows the good biocompatibility to the body immune system during HD therapy 
(Sasaki, 2006). Some studies suggested that high flux dialyzer membrane was better 
due to a lower death rate than the low flux dialyzers (Bloembergen et al., 1999; 
Woods et al., 2000). The Eknoyan et al. (2002) reported a HD study of 72 patients in 
15 clinical centers and checked the mortality and morbidity. He found that neither 
the high flux rate nor higher dialysis dose enhanced the mortality and morbidity rate 
among patients. Besides, no much difference was found in the clearance rate of urea 
solute for the both high and low flux membranes (Eknoyan et al., 2002). The 
previous study of Bonomini et al. (1995) also provided the same results as Eknoyan 
et al. (2002) (Bonomini et al., 1995). Moreover, House et al., (2000) found that high 
flux membranes, increased the cardiovascular risk in the ESRD patients.  
The chief constituent of a hemodialysis instrument is a semipermeable 
membrane, whose chemical composition has great effect on a patient‘s health either 
in terms of membrane biocompatibility or uremic waste removal (Daugirdas et al., 
2012; Kumar et al., 2014; Nie et al., 2012; Zhao et al., 2013). Some of the most 
commonly used materials to make HD membranes include PSf, PES, polyamide, 
ethylene vinyl alcohol copolymers, cellulose triacetate, polymethylmethacrylate and 
polyacrylonitrile (Matsuda, 2011). Currently, synthetic polymers are used in most of 
the dialyzer membranes, 93% of which are derived from the parent polyarylsulfone 
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family, with 22% produced from PES and 71% from PSF (Bowry et al., 2010). Each 
polymeric membrane has its own advantages or disadvantages and complications 
may arise, when the membranes are judged only by their polymer names. Due to the 
varying membrane compositions, membranes with the same polymer names may 
differ in their adsorption, flux properties and hemocompatibility characteristics. 
Membranes in the new super high-flux dialyzers are primarily PSf and PES and 
future trends to use PES as main hemodialyzer materials are increasing because PES 
has an equivalent property to that of PSf, but it is considered as a bisphenol-A free 
membrane (Matzke et al., 2011; Yamasaki et al., 2001).   
PES has a higher atomic weight ratio of sulfone groups, which makes it more 
mechanical resistant, heat resistant and additional hydrophilic than that of PSf (Abe 
et al., 2011). PES is highly amorphous, transparent thermoplastic, comparatively less 
flammable, chemical resistant, relatively hydrophobic and has less water sorption 
(0.8% at 50% relative humidity) (Kesting, 1985). In biomedical fields PES 
membranes are broadly employed for artificial organs and medical devices used for 
purification of blood like hemofiltration, hemodiafiltration, hemodialysis, plasma 
collection and plasmapheresis (Samtleben et al., 2003; Tullis et al., 2002; Werner et 
al., 1996; Zhao et al., 2013). 
In order to improve the performance of PES membrane in terms of  
biocompatibility and uremic solute removal, PVP was frequently used with PES and 
very little work was reported relating to PVP-K30. PVP is a highly hydrophilic and 
water-soluble polymer that prevents the protein adsorption and act as a pore forming 
agent on the membrane surface (Yang et al., 2008). The high affinity of PVP may 
cause it to swell in aqueous media and then it is eluded during phase inversion and 
blood dialysis. Thus, it may be possible that HD property of the membrane is altered 
during dialysis therapy (Sun et al., 2009). In order to maintain the composition of the 
membrane and retention of PVP as an additive in PES, PVP was used in the form of 
mono, di and tri-blocks such as poly(styrene-co-acrylic acid)-b-poly(vinyl 
pyrrolidone)-b-poly(styrene-co-acrylic acid) (Remes et al., 1992), poly(vinyl 
pyrrolidone)–b-poly(methyl methacrylate)–b-poly(vinyl pyrrolidone) (Ran et al., 
2011), poly(vinyl pyrrolidone-acrylonitrile-vinyl pyrrolidone ) (Yin et al., 2012),  
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poly(acrylonitrile-co-acrylic acid) (Fang et al., 2009), PVP nanoparticles (Weifeng-
Zhao et al., 2011) and PVP-k90 alone (Barzin et al., 2004).  
The use of nanoparticles and nanotubes has revealed outstanding potential in 
biological systems and membranes. In view of this MWCNTs are verified  and 
reported as a revolutionary choice in biomedical field such as biomolecular 
transporters and recognition devices (Shi Kam et al., 2004; Wilson et al., 2009), 
biosensors (Krauss, 2009), cancer therapy and diagnoses (De La Zerda et al., 2008; 
Liu et al., 2009). It is believed that the high surface to volume ratio of MWCNT can 
improve the overall performance of many polymer-CNT composite membranes. 
Moreover, MWCNT can be easily functionalized with different functional groups 
and provide sites for attachment or bonding to other incoming molecules and open up 
new applications (Vivekchand et al., 2002). Both covalent and non-covalent 
alterations of the MWCNT surfaces have been employed to improve the solubility 
and wetting of MWCNT. The non-covalent approach includes surfactant modifiers 
(Kang et al., 2003), polymer absorption (Gómez et al., 2003), and polymer wrapping 
(Star et al., 2001). The benefit of noncovalent connection is that the perfect structure 
of the MWCNT is maintained and the wrapped or absorbed compound is not 
damaged, and thus most of the properties remained intact (Chen et al., 2005). 
 Problem Statement 1.2
Koopman et al., (2008) reported that current HD therapy failed to replace the 
complicated functions of the kidney in ESRD patients. Numerous research has been 
carried out  in this field, however, patients suffer in chronic kidney disease were still 
suffering from low sickness situations, normal life quality and low death rate. The 
ESRD patients also suffered from chronic malnutrition, short life period and high 
cardiovascular risks (Koopman et al., 2008). Although, the HD technology had been 
used as a replacement therapy for renal failure for a few decades, it still has a number 
of unsolved issues. 
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Blood proteins have a propensity to rapidly adsorb onto the surface of the 
polymer, when PES-based hemodialysis membranes come into contact with blood 
(Klinkmann et al., 1987). Consequently the adsorbed protein layer demonstrated 
unwanted results such as higher platelet adhesion, fast blood coagulation and 
aggregation (Fang et al., 2009; et al., 2009; Zhu et al., 2007). The biocompatibility of 
the pristine PES was not satisfying (Klinkmann et al., 1987; Liu et al., 2009; 
Samtleben et al., 2003; Tullis et al., 2002; Zhao et al., 2013), thus the quest for 
simple additives and modification methods to improve such property continued and 
is a challenge for membranologists. 
Most of the results obtained from di or tri block of PVP suggested that they can 
be used in hemodialysis, but their actual dialysis performance in terms of blood 
compatibility are not well reported in the literature. Moreover, the preparation of the 
covalently combined di or tri block of PVP require highly specific and controlled 
conditions. Among the various modification techniques, the blending of PVP, is the 
simplest method to improve the biocompatibility of PES membranes, but pure PVP 
cannot be used directly and need slight modification for its permanent residence on 
the HD membrane (Matsuda et al., 2008). 
The MWCNTs are highly hydrophobic and non-polar material and its direct 
use without surface modification or surfactants may cause agglomeration and poor 
dispersion in membrane matrix, leading to defective product. The properties of 
MWCNT can be easily improved or upgraded by the attachment of different 
functional groups (Bahr et al., 2001; Georgakilas et al., 2002; Pekker et al., 2001; 
Valcárcel et al., 2008; Ying et al., 2003). Acid treatment is the simplest chemical 
method to create the polarity and attachment of the hydrophilic functional groups 
(carboxyl and hydroxyl) with MWCNT surface. This hydrophilic-hydrophobic nature 
of acid functionalized f-MWCNT provide a dual character, that can attract and bind 
both hydrophobic (like PES polymer) and hydrophilic types of chemicals (e.g. PVP 
type hydrophilic compounds) by - stacking and dipole-dipole interactions, 
respectively (Dyke et al., 2004a; Lu et al., 2011; Ma et al., 2010; Qian et al., 2000; 
Xie et al., 2005). 
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Most of the blood proteins are negatively charged and thus exhibit reduced 
adsorption behavior towards anionic character polymers. Sulfonation of PES is the 
bulk modification method which can increase the percentage of negative charge 
polarity due to the addition of sulfonated (-SO3H) group. The presence of sulfonate 
functional groups in the polymer reduced the blood and membrane interaction via 
steric repulsion and showed good anticoagulant activity. Sulfonation is a chemical 
modification method of the PES that enhanced its biocompatibility and 
hydrophilicity. Many studies had focused on the sulfonation of polymers that 
increased the anionic character (Nie et al., 2014; Wang et al., 2009).  Gertz et al., 
(2005) found that S-PES polymer reduced the contact activation of blood, whereas 
Wang et al., (2009) reported that blending of S-PES reduced the protein adsorption 
and elevated the blood coagulation time.  
There are many dialysis membranes on the market, but the high death ratio of 
ESRD patients is suggesting that more research need to be done on this issue (Saran 
et al., 2015). Moreover, a few researchers reported the self-synthesized performance 
of HD membranes and most of the published work are focused on the performance 
investigation of commercial dialyzer membranes (Jalal Barzin et al., 2004; Leypoldt 
et al., 2006; Li et al., 2012; Su et al., 2008).  In this research work, keeping in view 
the above discussion and literature review, an effort has been made to develop a 
highly biocompatible HD membrane composed of PES as a basic polymer with 
improved uremic solute permeability. Since the biocompatibility of PES HD 
membranes does not depend on a particular factor, hence different techniques are 
utilized to improve this property. Some of the researchers have focussed to chemical 
modification of PES polymer and others have used different additives (Ran et al., 
2011; Wang and Yang, et al., 2009).  The use of both methods, polymer modification 
and blending of additives together; have attracted much attention to improving the 
PES biocompatibility and uremic solute removal ability. 
In this work, effort was made to improve the performance and 
biocompatibilty of PES membranes by the chemically modified sulfonated PES and 
blending of novel nanocomposites (NCs) additives. The acid functionalized 
MWCNT and lower and higher molecular weight of PVP grades (PVP-k30 and PVP-
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k90) was used for NCs preparation and then they were incorporated  into PES and S-
PES/PES based membranes. The hydrophilic part of f-MWCNT contributed to the -
COOH and –OH groups, whereas sulfonated polymer provided the –SO3H group in 
the membrane composition.The S-PES increased the anionic character and 
hydrophilicity of the HD membrane and favor the reduced protein adhesion. While in 
the NC‘s, the PVP tended to enhance the biocompatibility and hydrophilicity and f-
MWCNT provided the mechanical strength, reduced the PVP leaching and act as a 
bridging material between PVP and PES. Moreover, the PVP was also reported as a 
surfactant for carbon nanotubes that improved its dispersibility and reduced the 
agglomeration in different solvents. Therefore, PVP in situ with acid treated 
MWCNT might also improve the dispersion properties of MWCNT in the formulated 
membranes (Vatanpour et al., 2011).  
Thus, the purpose of this research work is to contribute in the development of 
a new HD membrane with a combination of additives, which might be able to reduce 
biocompatible issues and exhibits higher rates of uremic solute clearances 
 Objective of the Study 1.3
The main objective of the study is to develop a high performance, 
biocompatible dialysis membrane with notable uremic solute sieving properties by 
blending f-MWCNT into the polymer matrix. In order to achieve this the following 
objectives, need to be addressed;  
1. To formulate and synthesize various flat sheet HD membranes consisting of 
i) PES as base polymer and NC‘s which consists of f-MWCNT/PVP-k90 
and f-MWCNT/PVP-k30. ii) Various ratios of PES and S-PES as the base 
polymer and the NCs which comprise of f-MWCNT/PVP-k90. 
 
2. To characterize the synthesized membranes in terms of chemical 
composition, biocompatibility and to evaluate their dialysis performance 




3. To fabricate HD hollow fiber membrane using the best formulation and 
analyse its dialysis performance.  
 Scope of the Study 1.4
The scope of research is as follows 
i. Acid functionalization of MWCNT and NC‘s synthesis by blending 
technique and covalent attachment of sulfonated group to the PES to 
develop S-PES polymer. The FTIR and XRD were used to 
characterize the MWCNT, f-MWCNT, NC‘s and S-PES polymer. 
ii. Preparation of  i) various concentrations of NC‘s and PES alone, ii) 
various ratios of S-PES and PES polymer with NC‘s via microwave 
technique. 
iii. Flat sheet membranes were casted and their chemical properties were 
analysed by FTIR, whereas FESEM was used for morphological 
studies. 
iv. The performance of HD membranes was initially evaluated in terms 
of pure water permeation, the molecular weight cutoff (MWCO) 
(should be <60kDa), mean pore size, porosity and flux recovery ratio. 
v. The leaching tests were performed to observe the stability of the NC‘s 
in the fabricated membranes  
vi. The membrane hydrophilicity were determined by contact angle and 
water uptake measurements. In addition, AFM technology was 
utilized for the surface roughness study and 3D micrographs. 
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vii. In order to evaluate the biocompatibility of HD membranes, various 
experiments are performed; protein resistance ability of FSMs,  
hemolysis (destruction of red blood cells), blood coagulation factors, 
including Thrombin time (TT), Prothrombin time (PT), Activated 
partial thrombin time (APTT), fibrin formation, and the plasma re-
calcification time. 
viii. The single layer dialysis cell is used to estimate the dialysis properties 
formulated membranes using a model solution of uremic solutes 
consisting of urea, creatinine and lysozyme against distilled water as 
dialysate. 
ix. Finally, hollow fiber membranes were fabricated using the best FSM 
formulation. Their performances were evaluated in terms of molecular 
weight cutoff, pure water permeation, pore size, antifouling properties 
and dialysis ability against uremic solutes.   
 Significance of the Study 1.5
In this research a novel HD membrane with excellent biocompatibility, good 
flux rate, better antifouling properties and excellent dialysis performance was 
synthesized and produced. PVP and the f-MWCNT based di-block nonocomposites 
were developed by simple blending method and its influence on PES and combine 
PES/S-PES polymeric membranes were thoroughly investigated with special 
emphasis on membrane biocompatibility, consistency of chemical composition, 
dialysis and typical HD performances. The biocompatibility tests include the study of 
protein adhesion, red blood cell behavior and fibrin formation towards the 
formulated membranes. Although previous researchers have used different 
modification techniques to enhance the performance of PES, but none of them has 
reported a comprehensive study in terms of typical membrane performance, 
biocompatible studies and dialysis of uremic solutions. Finally, the performance data 
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